Trials / Completed
CompletedNCT07493343
EUSOL vs. PDGF Dressing for Diabetic Foot Ulcers
Comparison of EUSOL Dressing Versus Platelet Derived Growth Factor Dressing in Wound Contraction of Grade II Wagner Diabetic Foot Ulcers: A Randomized Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 120 (actual)
- Sponsor
- Services Hospital, Lahore · Other Government
- Sex
- All
- Age
- 30 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
Diabetic foot ulcers are a major cause of morbidity and amputation. This randomized controlled trial will compare the efficacy of a traditional antiseptic dressing (EUSOL) with a modern biologic dressing containing Platelet-Derived Growth Factor (PDGF) in promoting wound contraction. The study aims to determine if PDGF dressing leads to better healing outcomes in patients with Grade II Wagner diabetic foot ulcers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | EUSOL Dressing | Daily dressing with freshly prepared Edinburgh University Solution of Lime (EUSOL) applied to the ulcer after standard debridement and cleansing. |
| PROCEDURE | Platelet-Derived Growth Factor (PDGF) Dressing | PDGF-based topical preparation applied to the ulcer surface every fourth day, covered by a secondary dressing. Interim dressing changes used normal saline only. |
Timeline
- Start date
- 2020-01-01
- Primary completion
- 2025-12-31
- Completion
- 2026-01-10
- First posted
- 2026-03-25
- Last updated
- 2026-03-25
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07493343. Inclusion in this directory is not an endorsement.